Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nuclear receptor subfamily 2 group C member 2 (NR2C2), also known as testicular receptor 4 (TR4), is a member of the nuclear hormone receptor family, functioning as a ligand-activated transcription factor and acting as either a repressor or activator of transcription. NR2C2 regulates diverse biological processes such as development, cellular differentiation, homeostasis, and spermatogenesis, and can modulate gene expression of various nuclear receptor signaling pathways. It has protective roles against oxidative stress and radiation-induced damage. The gene is implicated in disease processes including aging, cancer, and neurodevelopmental abnormalities.
Repression or activation of transcription of nuclear receptor signaling pathways (e.g., retinoic acid receptor, retinoid X receptor, vitamin D3 receptor, thyroid hormone receptor, estrogen receptor pathways); Modulation of gene expression by binding to hormone response elements
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nuclear receptor subfamily 2 group C member 2 (NR2C2).